Show all abstracts Show selected abstracts Add to my list |
|
|
Letter to Editor: Change paradigm in the face of COVID-19; From bans to incentives |
|
Alireza Jabbari, Elaheh Mazaheri, Marziye Hadian Int J Prev Med 2021, 12:176 (30 December 2021) DOI:10.4103/ijpvm.ijpvm_83_21 |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Citations (2) ] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Letter to Editor: New COVID-19 Variant, VUI-202012/01: Molecular change, epitope alteration, and implication for vaccine efficacy |
|
Beuy Joob, Viroj Wiwanitkit Int J Prev Med 2021, 12:172 (14 December 2021) DOI:10.4103/ijpvm.IJPVM_708_20 |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Letter To Editor: Preventive medicine for prevention measurement for COVID-19, State quarantine |
|
Viroj Wiwanitkit Int J Prev Med 2021, 12:112 (21 September 2021) DOI:10.4103/ijpvm.IJPVM_400_20 |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Letter To Editor: The health crisis caused by the new coronavirus and the underground world of noninfluenza respiratory viruses: The need for a global surveillance plan |
|
Piero Schiro, Luigi Galvano, Luigi Spicola Int J Prev Med 2021, 12:81 (5 July 2021) DOI:10.4103/ijpvm.ijpvm_722_20 |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Letter to Editor: Renin angiotensin converting enzyme 2 and COVID-19: Prevention and treatment |
|
Marzieh Kafami, Mehdi Nematbakhsh Int J Prev Med 2021, 12:70 (25 June 2021) DOI:10.4103/ijpvm.IJPVM_585_20 |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Letter to Editor: Expected RATE of vaccine-associated paralytic poliomyelitis: A simulation analysis regarding transition from the trivalent to bivalent oral poliovirus vaccine |
|
Int J Prev Med 2021, 12:49 (27 May 2021) DOI:10.4103/ijpvm.IJPVM_293_19 |
[HTML Full text] [PDF] [Mobile Full text] [EPub] [Sword Plugin for Repository]Beta |
|
|
|
|
|